Exhibit 99.1

PRGX GLOBAL, INC.
THIRD QUARTER 2010 FINANCIAL RESULTS

Operating Highlights

• Fourth straight quarter of year-over-year revenue growth

• Strong sales activity in all service lines

• Ramp-up of Medicare Recovery Audit Contractor (RAC) Program moving ahead

• Successful launch of India off-shore services center

ATLANTA, October 25, 2010 — PRGX Global, Inc. (Nasdaq: PRGX), the world’s leader in recovery auditing and the pioneer in profit discovery services, today announced its unaudited financial results for the third quarter ended September 30, 2010.

“I am pleased to report that the implementation of our growth strategy continued to yield positive returns during the third quarter of 2010, our fourth consecutive quarter of year-over-year revenue growth. PRGX continues to bolster its service offerings and invest in several initiatives, with the largest investments being made in our core recovery audit business. We are now piloting our next- generation recovery audit platform, and have enhanced our sales capabilities across all our service lines. I am confident that our investments are making us more formidable in the marketplace and will promote future growth,” said Romil Bahl, president and chief executive officer.

“As expected, revenues from our participation in the Medicare Recovery Audit Contractor (RAC) program ramped up in the third quarter. By the time we report our quarterly earnings a year from now, we expect to be at steady state revenues in this important program. With our proven healthcare audit capabilities and the recently added sales resources, we believe we are well positioned to compete for additional work in this bourgeoning market. A significant portion of the growth in this market will be driven by government payers, and we are encouraged by the recent letter from the Centers for Medicare and Medicaid Services clarifying that each state must implement a RAC program by April 2011,” continued Mr. Bahl.

Discussion of Consolidated Results for Three Months Ended September 30, 2010:

Consolidated revenue for the 2010 third quarter amounted to $46.9 million, reflecting a 3.5% increase from the third quarter of 2009. After adjustment for changes in foreign exchange rates, consolidated third quarter revenues in 2010 increased 4.3% compared to the same period in 2009. Reported revenue for the 2010 third quarter increased by $1.4 million, or 3.1%, compared to the second quarter of 2010.

Total cost of revenues amounted to $32.0 million in the 2010 third quarter compared to $29.0 million in the same prior year period. The increase in cost of revenues reflects the additional investments the Company is making in its previously announced growth strategies, particularly in healthcare.

SG&A for the 2010 third quarter was $10.9 million compared to the prior year’s amount of $11.0 million. SG&A includes the impact of changes in foreign currency exchange rates on intercompany

1

balances, including gains of $1.3 million for the 2010 third quarter and gains of $0.7 million for the 2009 third quarter.

Net earnings for the 2010 third quarter were $2.6 million, or $0.11 per basic and diluted share, compared to net earnings of $6.4 million, or $0.27 per basic and diluted share for the same period in 2009. The third quarter 2010 net earnings included a charge of $1.2 million related to stock-based compensation, a $0.1 million charge for acquisition obligations classified as compensation and the $1.3 million of foreign currency gains on intercompany balances. The third quarter 2009 net earnings included a $1.5 million charge for stock-based compensation, a $2.4 million net gain related to a bargain purchase in connection with the Company’s acquisition of First Audit Partners in July 2009, and the $0.7 million of foreign currency gains on intercompany balances.

Adjusted EBITDA for the 2010 third quarter was $6.3 million compared to $7.8 million of adjusted EBITDA for the same period in 2009. The 2010 third quarter adjusted EBITDA is earnings before interest, taxes, depreciation and amortization (EBITDA) excluding the charge of $1.2 million related to stock-based compensation, the $1.3 million of foreign currency gains on intercompany balances and the $0.1 million charge for acquisition obligations classified as compensation. The comparable adjusted EBITDA amount for the third quarter of 2009 excludes from EBITDA for such period the $1.5 million charge for stock-based compensation, the $2.4 million gain on a bargain purchase and the $0.7 million of foreign currency gains on intercompany balances. (Schedule 3 attached to this press release provides a reconciliation of net earnings (loss) to each of EBITDA and adjusted EBITDA).

Added Mr. Bahl, “I was delighted to recently visit our new operation in Pune, India — as well as several of our teams and clients across other countries in Asia. While we are starting cautiously, as we gain experience with offshoring as a company, we will increasingly view the PRGX global delivery model as a major asset with broad applicability across our service lines and support functions. It is exciting to see first hand the kind of global talent we are increasingly able to attract into the new PRGX.”

“Also, during the third quarter, we continued to gain traction in the marketplace with our unique client value propositions combining Business Analytics and Advisory Services. Early client reaction in both Europe and the Americas to this service combination has been extremely positive. We view our Spend Analytics solution as helping deliver the next generation of spend management and related client profits, and are excited about our newly incubated Fraud Analytics toolkit and related services. We are so convinced of the power of these client value propositions that we are renewing our commitment to the growth of these new service lines as part of our annual strategy checkpoint and business planning process,” continued Mr. Bahl.

“In just a year after announcing our strategy to reposition PRGX for growth, I am pleased with the progress to date and our ability to navigate a challenging economic environment. We look forward to aggressively pursuing the numerous opportunities in front of us,” concluded Mr. Bahl.

Discussion of Segment Results for Three Months Ended September 30, 2010:

Recovery Audit Services — Americas revenues for the 2010 third quarter were $29.7 million compared to the prior year’s third quarter revenues of $31.8 million, a decrease of 6.5%. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services — Americas revenues

2

decreased by 7.7% compared to 2009. Gross margin was significantly impacted by investments we are making in our growth strategies. Significant portions of the non-capitalizable amounts of these costs are being absorbed within the Americas segment cost of revenues.

Recovery Audit Services — Europe Asia/Pacific revenues for the 2010 third quarter were $14.8 million compared to $12.2 million in the prior year’s quarter, an increase of 21.2%. On a constant dollar basis, adjusted for changes in foreign exchange rates, Recovery Audit Services — Europe Asia/Pacific third quarter 2010 revenues increased by 27.2% compared to 2009.

New Services revenues for the 2010 third quarter were $2.3 million compared to the prior year’s third quarter revenues of $1.3 million, an increase of 80.9%. New Services revenues in the 2009 third quarter were primarily derived from financial advisory services. New Services revenues in the 2010 third quarter were primarily derived from financial advisory services and from our participation in the Medicare RAC program.

Discussion of Consolidated Results for Nine Months Ended September 30, 2010:

Total revenue for the nine months ended September 30, 2010 increased 2.8% to $133.7 million, compared to $130.0 million for the same period in 2009. After adjusting for changes in foreign exchange rates, 2010 first nine months revenues increased 1.4% compared to the first nine months of 2009.

Cost of revenues in the first nine months of 2010 amounted to $93.2 million compared to $83.7 million for the comparable 2009 period. As noted with regard to the Company’s gross margin performance for the third quarter, the increase in cost of revenues for the nine months ended September 30, 2010 is attributable to the Company’s investments in growth initiatives.

SG&A for the nine months ended September 30, 2010 was $36.8 million compared to $31.5 million for the same period in the prior year. SG&A for the nine months ended September 30, 2010 includes foreign currency losses on intercompany balances of $0.4 million, compared to gains of $1.8 million for the same period in 2009.

Net loss for the nine months ended September 30, 2010 was $0.8 million, or $0.04 per basic and diluted share, compared to net earnings of $13.3 million, or $0.59 per basic and $0.57 per diluted share for the same period in 2009. The nine months ended September 30, 2010 net loss included a charge of $3.0 million related to stock-based compensation, a $0.3 million charge for acquisition obligations classified as compensation, and the $0.4 million of foreign currency losses on intercompany balances. The nine months ended September 30, 2009 net earnings included a $2.5 million charge for stock-based compensation, a $0.7 million charge related to a litigation settlement, the $2.4 million gain related to a bargain purchase and the $1.8 million of foreign currency gains on intercompany balances.

Adjusted EBITDA for the nine months ended September 30, 2010 was $14.1 million compared to $20.6 million of adjusted EBITDA for the same period in 2009. The nine months ended September 30, 2010 adjusted EBITDA is earnings before interest, taxes, depreciation and amortization (EBITDA) excluding the charge of $3.0 million related to stock-based compensation, the $0.4 million of foreign currency losses on intercompany balances and the $0.3 million charge for acquisition obligations classified as compensation. The comparable adjusted EBITDA amount for the same period in 2009

3

excludes from EBITDA for such period the $2.5 million charge for stock-based compensation, the $0.7 million litigation settlement charge, the $2.4 million gain from a bargain purchase and the $1.8 million of foreign currency gains on intercompany balances. (Schedule 3 attached to this press release provides a reconciliation of net earnings (loss) to each of EBITDA and adjusted EBITDA).

Third Quarter Earnings Call

As previously announced, management will hold a conference call tomorrow morning at 8:30 AM (Eastern Time) to discuss the Company’s third quarter 2010 financial results. To access the conference call, listeners in the U.S. and Canada should dial 800-901-5248 at least 5 minutes prior to the start of the conference. Listeners outside the U.S. and Canada should dial 617-786-4512. To be admitted to the call, listeners should use passcode 66553594. A replay of the call will be available approximately two hours after the conclusion of the live call, extending through November 26, 2010. To directly access the replay, dial 888-286-8010 (U.S. and Canada) or 617-801-6888 (outside the U.S. and Canada). The passcode for the replay is 64983692.

This teleconference will also be audiocast on the Internet at www.prgx.com (click on “Audio Archives” under “Investors”). A replay of the audiocast will be available at the same location on www.prgx.com beginning approximately two hours after the conclusion of the live audiocast, extending through November 26, 2010. Please note that the Internet audiocast is “listen-only.” Microsoft Windows Media Player is required to access the live audiocast and the replay and can be downloaded from www.microsoft.com/windows/mediaplayer.

About PRGX Global, Inc.

Headquartered in Atlanta, PRGX Global, Inc. is the world’s leading provider of recovery audit services. With more than 1,300 employees, the Company operates and serves clients in more than 30 countries and provides its services to over 75% of the top 30 global retailers. PRGX is also pioneering profit discovery, a unique combination of audit, analytics and advisory services that improves client financial performance. Beyond its core retail practice, PRGX is actively pursuing initiatives to expand into new markets, most notably healthcare. For additional information, please visit PRGX at www.prgx.com.

Non-GAAP Financial Measures

EBITDA and adjusted EBITDA are both “non-GAAP financial measures” presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company’s performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to adjusted EBITDA is used in the restrictive covenants contained in the Company’s secured credit facility. However, EBITDA and adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBITDA and adjusted EBITDA, you should be aware that, as described above, the adjustments may vary from period to period and in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual

4

or nonrecurring items. Schedule 3 to this press release provides a reconciliation of net earnings to each of EBITDA and adjusted EBITDA.

Forward-Looking Statements

In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company’s financial condition and revenue growth, the success from its increased sales and marketing efforts and expansion of its service lines, and the success of its growth strategies and expansion into new markets, including anticipated opportunities in the healthcare industry. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company’s future performance include revenues that do not meet expectations or justify costs incurred, the Company’s ability to develop material sources of new revenue in addition to revenues from its core accounts payable services, changes in the market for the Company’s services, the Company’s ability to retain and attract qualified personnel, changes to Medicare and Medicaid recovery audit contractor programs, the Company’s ability to integrate recent and future acquisitions, uncertainty in the credit markets, the Company’s ability to maintain compliance with its financial covenants, client bankruptcies, loss of major clients, and other risks generally applicable to the Company’s business. For a discussion of other risk factors that may impact the Company’s business, please see the Company’s filings with the Securities and Exchange Commission, including its Form 10-K filed on March 29, 2010. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

Contact: PRGX Global, Inc.
Robert Lee
770-779-6464

5

SCHEDULE 1
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Amounts in thousands, except per share data)
(Unaudited)

	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2010		2009		2010			2009
Revenues	$	46,900	$	45,321	$	133,736		$	130,044
Cost of revenues		31,952		28,974		93,163			83,715
Gross margin		14,948		16,347		40,573			46,329
Selling, general and administrative expenses		10,895		11,001		36,820			31,497
Operating income		4,053		5,346		3,753			14,832
Gain on bargain purchase, net		—		2,388		—			2,388
Interest expense, net		315		728		2,351			2,154
Earnings before income taxes		3,738		7,006		1,402			15,066
Income taxes		1,177		605		2,241			1,767
Net earnings (loss)	$	2,561	$	6,401	$	(839	)	$	13,299
Basic earnings (loss) per common share	$	0.11	$	0.27	$	(0.04	)	$	0.59
Diluted earnings (loss) per common share	$	0.11	$	0.27	$	(0.04	)	$	0.57
Weighted average common shares outstanding:
Basic		24,218		23,404		23,798			22,735
Diluted		24,388		23,833		23,798			23,453

SCHEDULE 2
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Amounts in thousands)

	September 30,
	2010			December 31,
	(Unaudited)			2009
ASSETS
Current assets:
Cash and cash equivalents	$	20,244		$	33,026
Restricted cash		120			256
Receivables:
Contract receivables		30,785			32,515
Employee advances and miscellaneous receivables		737			276
Total receivables		31,522			32,791
Prepaid expenses and other current assets		3,535			2,335
Total current assets		55,421			68,408
Property and equipment, net		15,200			10,003
Goodwill		4,720			4,600
Intangible assets, net		22,551			24,104
Other assets		2,351			3,398
Total assets	$	100,243		$	110,513
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portions of debt obligations	$	3,000		$	3,260
Accounts payable and accrued expenses		12,460			15,707
Accrued payroll and related expenses		14,370			19,884
Refund liabilities and deferred revenue		8,691			8,383
Acquisition obligations		598			2,695
Total current liabilities		39,119			49,929
Debt obligations		9,750			11,070
Deferred income taxes		951			—
Noncurrent compensation obligations		165			978
Other long-term liabilities		6,556			7,097
Total liabilities		56,541			69,074
Shareholders’ equity:
Common stock		239			233
Additional paid-in capital		565,374			562,563
Accumulated deficit		(525,500	)		(524,661	)
Accumulated other comprehensive income		3,589			3,304
Total shareholders’ equity		43,702			41,439
Total liabilities and shareholders’ equity	$	100,243		$	110,513

SCHEDULE 3
PRGX Global, Inc. and Subsidiaries
Reconciliation of Net Earnings to EBITDA and Adjusted EBITDA
(Amounts in thousands)
(Unaudited)

	Three Months						Nine Months
	Ended September 30,						Ended September 30,
	2010			2009			2010			2009
Reconciliation of net earnings (loss) to EBITDA and to adjusted EBITDA:
Net earnings (loss)	$	2,561		$	6,401		$	(839	)	$	13,299
Adjust for:
Income taxes		1,177			605			2,241			1,767
Interest expense, net		315			728			2,351			2,154
Depreciation and amortization		2,291			1,634			6,602			4,342
EBITDA		6,344			9,368			10,355			21,562
Foreign currency (gain) losses on intercompany balances		(1,274	)		(678	)		438			(1,752	)
Litigation settlement		—			—			—			650
Acquisition obligations classified as compensation		106			—			265			—
Stock-based compensation		1,170			1,496			3,047			2,500
Gain on bargain purchase, net		—			(2,388	)		—			(2,388	)
Adjusted EBITDA	$	6,346		$	7,798		$	14,105		$	20,572

EBITDA and adjusted EBITDA are both “non-GAAP financial measures” presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company’s performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to adjusted EBITDA is used in the restrictive covenants contained in the Company’s secured credit facility. However, EBITDA and adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBITDA and adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

SCHEDULE 4
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
(Unaudited)

	Three Months						Nine Months
	Ended September 30,						Ended September 30,
	2010			2009			2010			2009
Cash flows from operating activities:
Net earnings (loss)	$	2,561		$	6,401		$	(839	)	$	13,299
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Gain on bargain purchase, net		—			(2,388	)		—			(2,388	)
Depreciation and amortization		2,291			1,634			6,602			4,342
Amortization of deferred debt costs		42			197			1,493			591
Stock-based compensation expense		1,170			1,496			3,047			2,500
(Increase) decrease in receivables		(753	)		(3,168	)		1,693			2,903
Decrease in accounts payable, accrued payroll and other accrued expenses		(4,638	)		(1,381	)		(9,308	)		(11,738	)
Other, primarily changes in assets and liabilities		(171	)		(611	)		(2,520	)		(1,869	)
Net cash provided by operating activities		502			2,180			168			7,640
Cash flows used in investing activities:
Business acquisitions		(1,474	)		(2,029	)		(5,315	)		(2,029	)
Purchases of property and equipment, net of disposals		(1,271	)		(656	)		(5,249	)		(2,065	)
Net cash used in investing activities		(2,745	)		(2,685	)		(10,564	)		(4,094	)
Net cash used in financing activities		(833	)		(1,354	)		(2,394	)		(4,253	)
Effect of exchange rates on cash and cash equivalents		1,011			706			8			1,348
Net increase (decrease) in cash and cash equivalents		(2,065	)		(1,153	)		(12,782	)		641
Cash and cash equivalents at beginning of period		22,309			28,482			33,026			26,688
Cash and cash equivalents at end of period	$	20,244		$	27,329		$	20,244		$	27,329

SCHEDULE 5
PRGX Global, Inc. and Subsidiaries
Results by Operating Segment *
(Amounts in thousands)
(Unaudited)

	Three Months Ended									Nine Months Ended
	September 30,									September 30,
	2010			2009			Change			2010			2009			Change
Revenues
Recovery Audit Services — Americas	$	29,740		$	31,794		$	(2,054	)	$	84,582		$	92,004		$	(7,422	)
Recovery Audit Services — Europe/Asia-Pacific		14,824			12,236			2,588			42,564			34,195			8,369
New Services		2,336			1,291			1,045			6,590			3,845			2,745
Total	$	46,900		$	45,321		$	1,579		$	133,736		$	130,044		$	3,692
Cost of revenues
Recovery Audit Services — Americas	$	17,560		$	17,031		$	(529	)	$	51,234		$	50,857		$	(377	)
Recovery Audit Services — Europe/Asia-Pacific		11,171			9,639			(1,532	)		32,701			27,015			(5,686	)
New Services		3,221			2,304			(917	)		9,228			5,843			(3,385	)
Total	$	31,952		$	28,974		$	(2,978	)	$	93,163		$	83,715		$	(9,448	)
Selling, general and administrative expenses
Recovery Audit Services — Americas	$	5,379		$	5,028		$	(351	)	$	15,979		$	12,881		$	(3,098	)
Recovery Audit Services — Europe/Asia-Pacific		303			754			451			4,969			3,275			(1,694	)
New Services		1,170			221			(949	)		2,832			888			(1,944	)
Corporate		4,043			4,998			955			13,040			14,453			1,413
Total	$	10,895		$	11,001		$	106		$	36,820		$	31,497		$	(5,323	)
Operating income
Recovery Audit Services — Americas	$	6,801		$	9,735		$	(2,934	)	$	17,369		$	28,266		$	(10,897	)
Recovery Audit Services — Europe/Asia-Pacific		3,350			1,843			1,507			4,894			3,905			989
New Services		(2,055	)		(1,234	)		(821	)		(5,470	)		(2,886	)		(2,584	)
Corporate		(4,043	)		(4,998	)		955			(13,040	)		(14,453	)		1,413
Total	$	4,053		$	5,346		$	(1,293	)	$	3,753		$	14,832		$	(11,079	)
Adjusted EBITDA
Recovery Audit Services — Americas	$	8,218		$	10,910		$	(2,692	)	$	21,815		$	31,482		$	(9,667	)
Recovery Audit Services — Europe/Asia-Pacific		2,645			1,517			1,128			6,791			2,962			3,829
New Services		(1,644	)		(1,131	)		(513	)		(4,508	)		(2,566	)		(1,942	)
Corporate		(2,873	)		(3,498	)		625			(9,993	)		(11,306	)		1,313
Total	$	6,346		$	7,798		$	(1,452	)	$	14,105		$	20,572		$	(6,467	)

* The Recovery Audit Services — Americas segment represents recovery audit services, excluding New Services, provided in the United States, Canada and Latin America. The Recovery Audit Services — Europe/Asia-Pacific segment represents recovery audit services provided in Europe, Asia and the Pacific region. The New Services segment represents services provided to healthcare organizations (including recovery audit services), financial advisory services and business analytics services.